To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Male Subjects (Trastuzumab)
Clinical trial NCT06687928 · COMPLETED
Trial details
- NCT number
- NCT06687928
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-26
- Primary completion
- 2025-08-05
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.